Surprising Results: FYI™ Lowers Men's PSA Levels
by Garry Gordon, m.d., d.o., m.d.(h.)

As a clinician and scientist, when I see wonderful changes in a patient's health, I always want to know why. Here is an example. I have been working with two male rheumatoid arthritis patients who were getting excellent results with FYI™ (For Your Inflammation) from Garden of Life. Jordan Rubin, N.M.D., C.N.C., one of our country's truly gifted formulators, created this formula.

I knew from extensive experience with the formula the wonderful reductions in pain and inflammation that the patients would experience. I didn't expect the significant reductions in their PSA counts.

PSA is a protein produced by the cells of the prostate gland. The prostate-specific antigen (PSA) test measures the level of PSA in the blood. A blood sample is drawn and the amount of PSA is measured in a laboratory. When the prostate gland enlarges, PSA levels in the blood tend to rise. PSA levels can rise due to cancer or benign (not cancerous) conditions. Because PSA is produced by the body and can be used to detect disease, it is sometimes called a biological marker or tumor marker.

PSA test results report the level of PSA detected in the blood. The PSA level that is considered normal for an average man ranges from 0 to 4 nanograms per milliliter (ng/ml). A PSA level of 4 to 10 ng/ml is considered slightly elevated; levels between 10 and 20 ng/ml are considered moderately elevated; and anything above that is considered highly elevated. My patients had levels between 10 and 20 ng/ml. The higher a man's PSA level, the more likely it is that cancer is present. But because various factors can cause PSA levels to fluctuate, one abnormal PSA test does not necessarily indicate a need for other diagnostic tests. When PSA levels continue to rise over time, other tests may be indicated. But one thing we know, high PSA values indicate men need to pay attention to their prostate health.

In this case, neither patient had detectable prostate cancer-but they were experiencing overall bodily inflammation, as confirmed with high sensitivity C-reactive protein tests. But the fact that we caught this inflammation early on and reduce to their levels to below four ng/ml is very important. In other words, it now appears that there is some link between elevated PSA levels and inflammation-and possibly prostate cancer. Consider this headline from the May 2002 issue of Health News: "Daily Aspirin May Thwart Prostate cancer." And we know that the main action of aspirin is as an anti-inflammatory.

Some 60 percent of all prostate cancer cases could probably be prevented if our patients stayed on long-term anti-inflammatory drugs; however, such drugs' side effects are often serious and not welcome in my practice, especially when I have tools like FYI™ to offer patients.

Editor's note: Dr. Gordon is available to patients on a consulting basis and can be reached via email at ggordon@gordonresearch.com or by phone at (928) 472-4263.

Disclaimer: These Articles and or information are not intended to mitigate the symptoms or cure the specific diagnosis of cancer or cancer related disease states.